affiliation not provided to SSRN
non-small cell lung cancer, clinical stage I-II, Lymph node metastasis, prediction model, lymph node dissection, Nomogram
high-grade neuroendocrine carcinoma, Small-cell lung cancer, large-cell neuroendocrine carcinoma, cisplatin, irinotecan, etoposide, Relative dose intensity